Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Morpholine | HCID 8083 | — |
| Reactant | HCID 90370188 | HCID 90370188 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 90370196 | HCID 90370196 | — |
Reaction Steps
To a mixture of 200 mg of 2-{[3-(chloromethyl)benzoyl]amino}-N-[4-(diethylamino)phenyl]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide and 8 mL of DMF was added 1.0 mL of morpholine, followed by stirring for 3 days at room temperature. The reaction mixture was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (chloroform:methanol:aqueous ammonia solution=50:1:0.1). The obtained residue was dissolved in a mixed solution of ethyl acetate and ethanol (4:1), and 1.0 mL of 4.0 M hydrogen chloride/ethyl acetate solution was further added thereto. The precipitated solid was collected by filtration, thereby obtaining 183 mg of N-[4-(diethylamino)phenyl]-2-{[3-(morpholin-4-ylmethyl)benzoyl]amino}-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide dihydrochloride.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09062032B2 |
|---|
| Source dataset | uspto-grants-2015_06 |
|---|
| ORD ID | ord-c6f263f281f84f8cbed0b20a3db8794f |
|---|
| Source note | uspto-grants-2015_06 |
|---|